- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03638752
The Impact of Comprehensive Education Before Gastroscopy on Improving the Tolerance of Patients
The Impact of Comprehensive Education Before Gastroscopy on Improving the Tolerance of Patients: A Prospective Randomized Controlled Study
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Zhejiang
-
Ningbo, Zhejiang, Kina, 315010
- Ningbo NO.1 hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients over the age of 18 years undergoing routine gastroscopy
- Informed consent
Exclusion Criteria:
- Serious coronary heart disease and myocardial injury with serious heart failure
- Stenosis of the esophagus or cardia obstruction
- Acute pharyngitis and tonsillitis
- Acute upper gastrointestinal bleeding
- Hemodynamically unstable
- allergy to topical lidocaine
- Patients did not cooperate or spirit was not normal
- Pregnancy
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Comprehensive education group
The details of Comprehensive education are as follows:
|
The details of Comprehensive education are as follows:
|
|
Inget ingripande: standard education
The details of standard education are as follows:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Adverse reaction times in gastroscopy
Tidsram: 1 day
|
research assistant records nausea/vomiting/retching times in the whole process of gastroscopy
|
1 day
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Patients' tolerance scores
Tidsram: 1 day
|
At the end of the procedure, the patients were asked about the tolerance in the process of gastroscopy by using a 100-mm visual analogue scale.
Tolerance includes the extent of pain and nausea.
The endpoints were assigned "no nausea or no pain " to the left and "worst possible nausea or worst pain imaginable " to the right.
|
1 day
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Endoscopists' assessment scores
Tidsram: 1 day
|
At the end of the procedure, Endoscopists scored the level of difficulty in introduction of the gastroscope on a 100-mm visual analogue scale. The endpoints were assigned " easiest" to the left and " worst difficult " to the right. Endoscopists' satisfaction was assessed with 100-mm VAS for the performances of the endoscopes. The endpoints were assigned " worst dissatisfied" to the left and " Most satisfied " to the right. |
1 day
|
|
Systolic/diastolic blood pressure (SBP/DBP)
Tidsram: 1 day
|
Patients were monitored the Systolic/diastolic blood pressure (SBP/DBP) throughout using an electronic multifunctional patient monitor unit.
The research assistant records Systolic/diastolic blood pressure (SBP/DBP) on 5 min prior to endoscopic intubation, during endoscopy and at time of entry into the stomach body
|
1 day
|
|
Pulse rate (PR)
Tidsram: 1 day
|
Patients were monitored the pulse rate (PR) throughout using an electronic multifunctional patient monitor unit.
The research assistant records pulse rate (PR) on 5 min prior to endoscopic intubation, during endoscopy and at time of entry into the stomach body.
|
1 day
|
|
Oxygen saturation by pulse oximetry (SpO2)
Tidsram: 1 day
|
Patients were monitored the Oxygen saturation by pulse oximetry (SpO2) throughout using an electronic multifunctional patient monitor unit.
The research assistant records oxygen saturation by pulse oximetry (SpO2) on 5 min prior to endoscopic intubation, during endoscopy and at time of entry into the stomach body.
|
1 day
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 2018-R010
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .